A Case Report on Zoledronic Acid as Palliative Treatment in Carcinoma of Lung with Bone Metastasis Cover

.blurhash-client-img { display: none !important; }

A Case Report on Zoledronic Acid as Palliative Treatment in Carcinoma of Lung with Bone Metastasis

Forum of Clinical Oncology

Volume 13 (2022): Issue 3 (December 2022)

By: Y. Sandhya, M. Swathi, G. Yeshavanth and V.T. Nagaraja

Open Access

|Jul 2023

Authors

Y. Sandhya

sandhyayogananda@gmail.com

Department of pharmacy practice, Bapuji Pharmacy College, Davangere, India

M. Swathi

Department of pharmacy practice, Bapuji Pharmacy College, Davangere, India

G. Yeshavanth

Department of General Medicine, SSIMS and RC, Davangere

V.T. Nagaraja

Department of General Medicine, SSIMS and RC, Davangere

DOI: https://doi.org/10.2478/fco-2023-0001 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X

Journal RSS Feed

Language: English

Page range: 49 - 51

Submitted on: Sep 8, 2022

|

Accepted on: Jan 26, 2023

|

Published on: Jul 4, 2023

Published by: Helenic Society of Medical Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

zoledronic acid,

palliative treatment,

bone metastasis,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology

© 2023 Y. Sandhya, M. Swathi, G. Yeshavanth, V.T. Nagaraja, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 13 (2022): Issue 3 (December 2022)Next article